Nimrata Hunt

CIK: 0001800619

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (25.0%)

Position reduction

Option Exercises (M)21 (52.5%)

Derivative conversions

Awards (A)7 (17.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IDXX

IDEXX LABORATORIES INC /DE

Officer

VEEV

VEEVA SYSTEMS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (40 total)

IDXX
IDEXX LABORATORIES INC /DE
Mar 3, 2026
Sale(S)
Direct
1.8K shares at avg. $634.57$1.1M
IDXX
IDEXX LABORATORIES INC /DE
Feb 26, 2026
Sale(S)
Direct
2.7K shares at avg. $661.54$1.8M
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
1.5K shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
301 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
207 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
204 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $629.35$726K
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
367 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Incentive Stock Option (right-to-buy)
Direct
162 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Non-Qualified Stock Option (right-to-buy)
Direct
4.6K shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Restricted Stock Unit
Direct
1.1K shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Restricted Stock Unit
Direct
1.6K shares-
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Exercise(M)
Direct
7.1K shares at avg. $288.78$2.1M
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Exercise(M)
Direct
5.4K shares at avg. $505.53$2.7M
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Sale(S)
Direct
5.1K shares at avg. $702.20$3.6M
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Sale(S)
Direct
1.5K shares at avg. $703.73$1.0M
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Sale(S)
Direct
1.5K shares at avg. $704.87$1.0M
IDXX
IDEXX LABORATORIES INC /DE
Nov 7, 2025
Sale(S)
Direct
1.4K shares at avg. $705.54$972K
IDXX
IDEXX LABORATORIES INC /DE
Aug 12, 2025
Exercise(M)
Direct
560 shares at avg. $178.26$100K
IDXX
IDEXX LABORATORIES INC /DE
Aug 12, 2025
Exercise(M)
Direct
483 shares at avg. $206.94$100K
IDXX
IDEXX LABORATORIES INC /DE
Aug 12, 2025
Exercise(M)
Direct
183 shares at avg. $544.08$100K
IDXX
IDEXX LABORATORIES INC /DE
Aug 11, 2025
Sale(S)
Direct
1.2K shares at avg. $656.53$788K
IDXX
IDEXX LABORATORIES INC /DE
Aug 6, 2025
Exercise(M)
Direct
5.7K shares at avg. $206.94$1.2M
IDXX
IDEXX LABORATORIES INC /DE
Aug 6, 2025
Exercise(M)
Direct
1.2K shares at avg. $141.60$172K
IDXX
IDEXX LABORATORIES INC /DE
Aug 6, 2025
Exercise(M)
Direct
5.9K shares at avg. $178.26$1.0M

		Type	Shares	Price		Ownership
Mar 3, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,758	$634.57	$1,115,577	Direct
Feb 26, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	2,693	$661.54	$1,781,531	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	1,508	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	301	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	207	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	204	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Tax Payment(F)	1,154	$629.35	$726,270	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	367	-	$0	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Incentive Stock Option (right-to-buy)	162	-	-	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Non-Qualified Stock Option (right-to-buy)	4,625	-	-	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Restricted Stock Unit	1,094	-	-	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Restricted Stock Unit	1,620	-	-	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	7,125	$288.78	$2,057,557	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	5,405	$505.53	$2,732,390	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	5,114	$702.20	$3,591,059	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,465	$703.73	$1,030,970	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,468	$704.87	$1,034,743	Direct
Nov 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,378	$705.54	$972,241	Direct
Aug 12, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	560	$178.26	$99,826	Direct
Aug 12, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	483	$206.94	$99,952	Direct
Aug 12, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	183	$544.08	$99,567	Direct
Aug 11, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,200	$656.53	$787,840	Direct
Aug 6, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	5,711	$206.94	$1,181,834	Direct
Aug 6, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	1,218	$141.60	$172,469	Direct
Aug 6, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	5,865	$178.26	$1,045,495	Direct

1-25 of 40 transactions

About Hunt Nimrata

Hunt Nimrata (SEC CIK 0001800619) files insider reports with the SEC as Executive Vice President of IDEXX LABORATORIES INC /DE (IDXX) and Director of VEEVA SYSTEMS INC (VEEV).

Signal8 holds 11 ownership filings by Hunt Nimrata, all Form 4s, filed between Sep 3, 2024 and Mar 5, 2026. Those filings report 40 transactions, from Sep 1, 2024 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hunt Nimrata's filings is in WESTBROOK, ME.

Recent filings by Hunt Nimrata

Mar 3, 2026: Open-market sale of IDXX shares (Form 4, code S).
Feb 26, 2026: Open-market sale of IDXX shares (Form 4, code S).
Feb 14, 2026: Option exercises of IDXX shares (4 lines, Form 4, code M).
Feb 14, 2026: Tax withholding of IDXX shares (Form 4, code F).
Feb 14, 2026: Option exercise of IDXX shares (Form 4, code M).

Other insiders filing for IDEXX LABORATORIES INC /DE (IDXX)

HOOLEY JOSEPH L, Director
Kingsley Lawrence D, Director
Emerson Andrew, EVP, CFO and Treasurer
FENNELL GEORGE, Executive Vice President
Vandebroek Sophie V., Director
SAMAD SAM, Director

How to read Form 4 transaction codes